Jeffrey W. Albers

Companies

• Aeglea BioTherapeuticsBoard member Nov 27, 2023 to now¹
• Kymera TherapeuticsBoard member Aug 20, 2020 to now²
• Blueprint Medicines CorpBoard member Apr 30, 2015 to now³
• Magenta TherapeuticsBoard member Jun 20, 2018 to Jun 30, 2022⁴
• Blueprint Medicines CorpChief executive officer Apr 30, 2015 to Apr 8, 2022³
• Blueprint Medicines CorpPresident Apr 30, 2015 to Apr 8, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAeglea BioTherapeutics SYRE9,360 shares⁵$800.9K at $85.57Aug 7, 2026
• BMBlueprint Medicines Corp0 shares⁶Jul 17, 2025
• KTKymera Therapeutics KYMR0 shares⁷Dec 8, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 7, 2026Sold 10,000 shares at $104.68 of Aeglea BioTherapeutics⁵
• Aug 7, 2026Sold 8,000 shares at $104.38 of Aeglea BioTherapeutics⁵
• Aug 7, 2026Sold 5,000 shares at $104.47 of Aeglea BioTherapeutics⁵
• Aug 7, 2026Exercised options 5,000 shares at $10.39 of Aeglea BioTherapeutics⁵
• Dec 8, 2025Sold 2,252 shares at $90.30 of Kymera Therapeutics⁷
• Dec 8, 2025Sold 2,748 shares at $89.32 of Kymera Therapeutics⁷
• Dec 8, 2025Exercised options 5,000 shares at $14.18 of Kymera Therapeutics⁷
• Oct 13, 2025Sold 5,000 shares at $59.19 of Kymera Therapeutics⁸
• Oct 13, 2025Exercised options 5,000 shares at $10.34 of Kymera Therapeutics⁸
• Jul 17, 2025U 144,755 shares of Blueprint Medicines Corp⁶
• Jul 17, 2025Returned to company 5,777 shares of Blueprint Medicines Corp⁶
• Jun 18, 2025Granted 3,902 shares at $128.12 of Blueprint Medicines Corp⁹
• Jun 3, 2025Sold 6,349 shares at $49.00 of Kymera Therapeutics¹⁰
• Jun 3, 2025Exercised options 6,349 shares at $10.34 of Kymera Therapeutics¹⁰
• May 27, 2025Sold 650 shares at $101.93 of Blueprint Medicines Corp¹¹
• May 27, 2025Sold 4,350 shares at $101.02 of Blueprint Medicines Corp¹¹
• May 27, 2025Exercised options 5,000 shares at $36.05 of Blueprint Medicines Corp¹¹
• Mar 12, 2025Sold 1,800 shares at $88.37 of Blueprint Medicines Corp¹²
• Mar 12, 2025Sold 5,700 shares at $87.62 of Blueprint Medicines Corp¹²
• Mar 12, 2025Exercised options 7,500 shares at $36.05 of Blueprint Medicines Corp¹²
• Mar 5, 2025Sold 5,766 shares at $88.80 of Blueprint Medicines Corp¹³
• Jan 21, 2025Sold 200 shares at $110.61 of Blueprint Medicines Corp¹⁴
• Jan 21, 2025Sold 7,400 shares at $109.92 of Blueprint Medicines Corp¹⁴
• Jan 21, 2025Sold 7,561 shares at $109.11 of Blueprint Medicines Corp¹⁴
• Jan 21, 2025Exercised options 10,000 shares at $36.05 of Blueprint Medicines Corp¹⁴